BACK TO ALL REFERENCES
Desentum: Patient-friendly and cost-efficient allergy vaccination
AllergyVax project includes first-in-human clinical trials of Desentum’s lead product candidate, an immunotherapeutic vaccine for birch pollen allergy.
We share what we learn
Read our latest news on our references
Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.
Horizon Europe
Health